JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.07B |
| 2 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.82B |
| 3 |
AT&T
T
|
+$779M |
| 4 |
Gilead Sciences
GILD
|
+$774M |
| 5 |
Eli Lilly
LLY
|
+$590M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.06B |
| 2 |
MON
Monsanto Co
MON
|
+$890M |
| 3 |
CVS Health
CVS
|
+$779M |
| 4 |
SLB Ltd
SLB
|
+$600M |
| 5 |
Chevron
CVX
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.33% |
| 2 | Healthcare | 12.01% |
| 3 | Technology | 10.9% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Pathward Financial
CASH
$1.87B
| $2.29M | ﹤0.01% |
+160,200
| New | +$2.19M |
|
|
EUHY
2677
iShares Euro High Yield Corporate Bond USD Hedged ETF
EUHY
$240M
| $2.29M | ﹤0.01% |
48,738
-5,525
| -10% | -$263K |
|
2678
Karyopharm Therapeutics
KPTI
$43.1M
| $2.29M | ﹤0.01% |
5,605
+2,438
| +77% | +$1.05M |
|
|
UBNK
2679
DELISTED
United Financial Bancorp, Inc.
UBNK
| $2.28M | ﹤0.01% |
169,825
+4,300
| +3% | +$55.5K |
|
2680
CALL
B&G Foods
BGS
$287M
| $2.28M | ﹤0.01% |
79,832
| – | – |
|
|
BEAT
2681
DELISTED
BioTelemetry, Inc.
BEAT
| $2.28M | ﹤0.01% |
241,600
-17,900
| -7% | -$166K |
|
2682
PUT
TSMC
TSM
$2.1T
| $2.27M | ﹤0.01% |
100,000
-838,000
| -89% | -$20M |
|
2683
Southside Bancshares
SBSI
$968M
| $2.27M | ﹤0.01% |
83,568
+1,859
| +2% | +$48K |
|
2684
Hecla Mining
HL
$9.49B
| $2.27M | ﹤0.01% |
863,061
+384,078
| +80% | +$1.18M |
|
2685
Build-A-Bear
BBW
$424M
| $2.27M | ﹤0.01% |
141,750
+85,905
| +154% | +$1.52M |
|
2686
Wolfspeed
WOLF
$1.23B
| $2.27M | ﹤0.01% |
87,005
-79,333
| -48% | -$2.49M |
|
|
DCOY
2687
Decoy Therapeutics
DCOY
$2.05M
| – | – |
0
| – | – |
|
2688
Enterprise Financial Services Corp
EFSC
$2.4B
| $2.26M | ﹤0.01% |
99,200
-1,420
| -1% | -$30.4K |
|
2689
PUT
The Mosaic Company
MOS
$7.04B
| $2.25M | ﹤0.01% |
48,100
| – | – |
|
|
STON
2690
DELISTED
StoneMor Inc.
STON
| $2.24M | ﹤0.01% |
74,415
+27,699
| +59% | +$827K |
|
2691
Marchex
MCHX
$76.6M
| $2.23M | ﹤0.01% |
451,613
-141,787
| -24% | -$665K |
|
|
WPX
2692
CALL
DELISTED
WPX Energy, Inc.
WPX
| $2.23M | ﹤0.01% |
+182,000
| New | +$2.4M |
|
2693
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.36B
| $2.23M | ﹤0.01% |
44,600
+363
| +0.8% | +$18.3K |
|
|
VTTI
2694
DELISTED
VTTI Energy Partners LP
VTTI
| $2.23M | ﹤0.01% |
89,027
+11,052
| +14% | +$284K |
|
|
RAD
2695
PUT
DELISTED
Rite Aid Corporation
RAD
| $2.23M | ﹤0.01% |
+13,328
| New | +$2.24M |
|
2696
Lattice Semiconductor
LSCC
$17.8B
| $2.22M | ﹤0.01% |
376,291
+250,241
| +199% | +$1.57M |
|
|
RT
2697
DELISTED
Ruby Tuesday Georgia
RT
| $2.21M | ﹤0.01% |
352,900
+226,600
| +179% | +$1.52M |
|
|
CVT
2698
DELISTED
CVENT, INC.
CVT
| $2.21M | ﹤0.01% |
85,850
+70,243
| +450% | +$1.91M |
|
2699
Cimpress
CMPR
$2.38B
| $2.21M | ﹤0.01% |
26,260
-6,758
| -20% | -$577K |
|
|
CVSA
2700
Covista Inc
CVSA
$4.23B
| $2.21M | ﹤0.01% |
73,650
-466,562
| -86% | -$15.4M |
|
Similar funds
JP Morgan Chase's Q2 2015 Portfolio in Review
As of Q2 2015, JP Morgan Chase held 4,397 positions worth $424B, down 3.4% from $439B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2015 filing shows 356 new, 1,656 increased, 1,613 reduced and 411 closed positions. Its largest new stake was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M. The largest sale was Johnson & Johnson, an estimated $1.06B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
- JP Morgan Chase's largest Q2 2015 buy was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.07B increase.
- JP Morgan Chase's biggest Q2 2015 reduction was Johnson & Johnson, cutting an estimated $1.06B.
- JP Morgan Chase fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $342M.
- JP Morgan Chase's ten largest holdings make up 17% of its $424B portfolio in Q2 2015.
- JP Morgan Chase opened 356 new positions and closed 411 in Q2 2015.
- JP Morgan Chase's portfolio value fell 3.4% quarter-over-quarter to $424B.
Based on JP Morgan Chase's 13F filing for Q2 2015, filed 14 Aug 2015.